Medical Spa and Wellness

Schedule a Complimentary Consultation (904) 928-9400

IncontilLase header

For a large majority of patients, typically two sessions are sufficient to alleviate mild or even moderate stress urinary incontinence.

IncontiLase Is Non-Invasive YAG Laser Therapy for Incontinence

How does IncontiLase work?

The IncontiLase treatment is based on precisely controlled laser-induced thermal effects in the mucosa tissue in the region of the vestibule and urethral orifice, as well as in the area along the anterior vaginal wall. The laser used in IntimaLase treatments is a 2940 nm Er:YAG, with built-in proprietary technology solutions that enable delivery of specially composed laser energy packages to the vaginal mucosa tissue and to collagen-rich endopelvic fascia. The resulting collagen neogenesis and remodeling leads to the shrinking and tightening of irradiated tissues, and the return of normal continence function.

Unique advantages of IntcontiLase

For a large majority of patients, typically two sessions are sufficient to alleviate mild or even moderate stress urinary incontinence. If needed, the treatment may be repeated after one month. No special pre-op preparations or post-op precautions are necessary. Patients may immediately return to their normal everyday activities. The procedure is incisionless and virtually painless, with no ablation, cutting, bleeding, or sutures. Recovery is extremely quick without need for the use of analgesics or antibiotics.






Scientifically proven clinical results

The latest IncontiLase scientific results, presented by LAHA specialists Dr. Riviera and Dr. Fistonić, show excellent improvement for mild and moderate stress urinary incontinence. Assessments of efficacy were based on subjective patients’ evaluations through standardized questionnaires as well as objective Q-tip and PFM measurements. 90% of patients with mild SUI and 76% of patients with moderate SUI needed just a single IncontiLase treatment. In total, 95% of all patients were incontinence free 12 months after the treatment, while 5% still had mild stress incontinence. Q-tip measurements during the Valsalva manouver resulted in an average 20° decrease in Q-tip angle, objectively showing improvements in the urethra and bladder neck status.